Yu-Ting Gan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yu-Ting Gan

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

American Journal of Therapeutics|February 11, 2026

Envafolimab-Associated Toxic Epidermal NecrolysisSheng Li, Ze Peng, Yu Qiu, et al.

Journal of the American Academy of Dermatology|June 27, 2026

Oral JAK Inhibitors in Adolescent Vitiligo: A Real-World Retrospective Study on Treatment Response and RecurrenceYu-Ting Gan, Shi Yan, Qing-Chun Diao, et al.

American Journal of Therapeutics|December 17, 2025

Sintilimab-Associated VitiligoSheng Li, Ze Peng, Yu-Ting Gan, et al.

American Journal of Therapeutics|March 23, 2026

Tislelizumab-Associated Bullous PemphigoidYao Lei, Yu-Ting Gan, Zhi-Jin Qiu, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

American Journal of Therapeutics|February 11, 2026

Envafolimab-Associated Toxic Epidermal NecrolysisSheng Li, Ze Peng, Yu Qiu, et al.

Journal of the American Academy of Dermatology|June 27, 2026

Oral JAK Inhibitors in Adolescent Vitiligo: A Real-World Retrospective Study on Treatment Response and RecurrenceYu-Ting Gan, Shi Yan, Qing-Chun Diao, et al.

American Journal of Therapeutics|December 17, 2025

Sintilimab-Associated VitiligoSheng Li, Ze Peng, Yu-Ting Gan, et al.

American Journal of Therapeutics|March 23, 2026

Tislelizumab-Associated Bullous PemphigoidYao Lei, Yu-Ting Gan, Zhi-Jin Qiu, et al.

Pageof 2